Filters

See more specimen types...

Other countries

Results: 1 to 20 of 38 (representing 19 labs)

Tests names and labsConditionsGenes and analytesMethods

Myotilinopathy

Centogene AG - the Rare Disease Company
Germany
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Comprehensive Neuromuscular Sequencing Panel

PreventionGenetics
United States
148124
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

MYOT. Complete sequencing

Instituto de Medicina Genomica
Spain
11
  • C Sequence analysis of the entire coding region

Myofibrillar Myopathy Sequencing Panel

PreventionGenetics
United States
1410
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Distal Hereditary Myopathy Sequencing Panel

PreventionGenetics
United States
2220
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Myotilinopathy Testing via the MYOT Gene

PreventionGenetics
United States
21
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Neuromuscular Comprehensive Panel

Courtagen Diagnostics Laboratory Courtagen Life Sciences
United States
454305
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Limb-Girdle Muscular Dystrophy Spotlight Panel

Courtagen Diagnostics Laboratory Courtagen Life Sciences
United States
8030
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Myofibrillar Myopathy Spotlight Panel

Courtagen Diagnostics Laboratory Courtagen Life Sciences
United States
238
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Distal Myopathy Spotlight Panel

Courtagen Diagnostics Laboratory Courtagen Life Sciences
United States
5719
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Muscular Dystrophy Advanced Evaluation

Athena Diagnostics Inc
United States
5633
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Myofibrillar Myopathy Advanced Sequencing Evaluation

Athena Diagnostics Inc
United States
239
  • C Sequence analysis of the entire coding region

Distal Myopathy Advanced Sequencing Evaluation

Athena Diagnostics Inc
United States
3117
  • C Sequence analysis of the entire coding region

Invitae Distal Myopathy Panel

Invitae
United States
2818
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae Myofibrillar Myopathy Panel

Invitae
United States
138
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae Comprehensive Myopathy Panel

Invitae
United States
5850
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae Comprehensive Neuromuscular Disorders Panel

Invitae
United States
141104
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Myofibrillar myopathy

GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases
Spain
2313
  • C Sequence analysis of the entire coding region

Myotilinopathy (sequence analysis of MYOT gene)

CGC Genetics
Portugal
11
  • C Sequence analysis of the entire coding region

Congenital and Distal Myopathies Panel

CeGaT GmbH
Germany
5273
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 38

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Support Center